These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 9462678)

  • 21. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
    Jung MS; Cimprich B
    Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy.
    O'Shaughnessy JA
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S116-20. PubMed ID: 12533272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
    J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
    Weis J; Poppelreuter M; Bartsch HH
    Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer.
    Boele FW; Schilder CM; de Roode ML; Deijen JB; Schagen SB
    Menopause; 2015 Jan; 22(1):17-25. PubMed ID: 24977455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
    Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
    Park JH; Bae SH; Jung YS; Jung YM
    J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study.
    Debess J; Riis JØ; Engebjerg MC; Ewertz M
    Breast Cancer Res Treat; 2010 May; 121(1):91-100. PubMed ID: 20306129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
    Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
    J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
    Adjuvant Breast Cancer Trials Collaborative Group
    J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.
    Hermelink K; Untch M; Lux MP; Kreienberg R; Beck T; Bauerfeind I; Münzel K
    Cancer; 2007 May; 109(9):1905-13. PubMed ID: 17351951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J;
    JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive function in breast cancer patients receiving adjuvant chemotherapy.
    Brezden CB; Phillips KA; Abdolell M; Bunston T; Tannock IF
    J Clin Oncol; 2000 Jul; 18(14):2695-701. PubMed ID: 10894868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
    Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
    Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment.
    Chen X; Li J; Ren J; Hu X; Zhu C; Tian Y; Hu P; Ma H; Yu F; Wang K
    Psychooncology; 2014 Oct; 23(10):1165-71. PubMed ID: 24737580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive functioning in breast cancer survivors: a controlled comparison.
    Jim HS; Donovan KA; Small BJ; Andrykowski MA; Munster PN; Jacobsen PB
    Cancer; 2009 Apr; 115(8):1776-83. PubMed ID: 19224550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
    Prokasheva S; Faran Y; Cwikel J; Geffen DB
    J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.
    Schagen SB; Muller MJ; Boogerd W; Van Dam FS
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S100-8. PubMed ID: 12533270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: a neuropsychological study.
    Chen X; Zhu C; Li J; Qiu L; Zhang L; Yu F; Ye R; Zhang J; Wang K
    Brain Res; 2013 Oct; 1533():63-72. PubMed ID: 23954744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.